Nov 11, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Nov 01, 2019 - Dr. Reddy's Laboratories Ltd (NYSE:RDY) Q2 2020 Earnings Conference Call November 01, 2019, 09:00 ET Company Participants Amit Agarwal - Director, Finance, FP&A and IR Saumen Chakraborty - Preside
Sep 30, 2019 - Mylan (MYL) sinks after the SEC charges it for misclassification of EpiPen.
Sep 23, 2019 - The Zacks Analyst Blog Highlights: Dr. Reddy's, WNS and Azure Power
Sep 20, 2019 - The government of India unveils an array of concessions to spur the economy. This in turn will slash most corporate taxes to 22% while new manufacturers will pay even a lower corporate tax rate of 15%.
Sep 19, 2019 - J&J's (JNJ) sNDA seeking approval of Erleada for metastatic castration-sensitive prostate cancer is based on data from TITAN study.
Sep 19, 2019 - Zynerba (ZYNE) announces positive top-line results from the BELIEVE 1 study evaluating the efficacy and safety of Zygel in a heterogeneous group of rare and ultra-rare epilepsies.
Sep 17, 2019 - Top Ranked Momentum Stocks to Buy for September 17th
Jun 10, 2019 - Dr. Reddy's (RDY) reports positive top-line results from the phase IIb study on PPC-06 (formerly referred to as XP23829) in patients with moderate to severe plaque psoriasis.
Jun 06, 2019 - BioMarin's (BMRN) Vimizim gains an NMPA nod in China for addressing patients suffering Morquio A syndrome, an ultra-rare genetic condition.